+13 13 0
Published 6 years ago by Gozzin with 0 Comments
by Gozzin
6 years ago

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients

Around 30% of patients with inflammatory bowel disease (IBD) are refractory to current IBD drugs or relapse over time. Novel treatments are called for, and low dose Naltrexone (LDN) may provide a safe, easily accessible alternative treatment option for ...

Continue Reading https://www.ncbi.nlm.nih.gov
Additional Contributions:

Join the Discussion

  • Auto Tier
  • All
  • 1
  • 2
  • 3
Post Comment

Here are some other snaps you may like...

discover your
interests.

Check out our front page for a lot more stuff!

Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place

Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn’s Disease: An IOIBD Initiative

Ulcerative colitis: bacteria findings raise hopes for new treatment

VBX-100: A GI-targeted prodrug of THC for Inflammatory Bowel Disease - Brandon Zipp

Stopping or reducing dietary fiber intake reduces constipation and its associated symptoms